Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
Lancet Diabetes Endocrinol
; 10(6): 418-429, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35468322
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Insulin Resistance
/
Islets of Langerhans
/
Diabetes Mellitus, Type 2
/
Insulins
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Lancet Diabetes Endocrinol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: